Chairman’s Statement
I am delighted to say that despite the current economic pressures affecting our patients, the quality, capability and long term sustainability of Integrated Dental Holdings (IDH) is growing strongly.
Since the end of the 2013 financial year, the business has successfully raised £400 million in the UK high-yield bond market and £100 million of new acquisition funding. IDH is now ideally placed to pursue its five-year growth strategy to increase the current 550 practices operated by the group to over 1,000 and annual revenues to over £650 million. IDH seeks to acquire a mix of National Health Service (NHS) and private dental practices as well as focussing on some key specialisms including Orthodontics, Implants and Endodontics in order to continue to grow the business and maintain our position as the largest dental body corporate in the world.
Our increasing network of sites and substantial investment in systems development, including Customer Relationship Management (CRM), will enable us to continue to innovate and develop our services to meet our patients’ changing needs in both private and NHS dentistry. We will ensure that the patient is at the heart of everything we do and strive to deliver “dentistry to smile about”.
Our partnerships with our clinicians and key suppliers remain an important part of our strategy, giving us the scale and breadth of service offering that our patients want. We are working hard to make sure all our partners understand our strategy and values, as they play an important part in us achieving collective success.
Working in partnership with NHS England, the Commissioning Board responsible for NHS dentistry in England, we continue to focus on maintaining the highest clinical standards and excellent customer service by investing in our clinical professionals, employees and in developing our practices, so that we really do become the provider of choice for patients.
Outlook
We remain focused on executing our strategy for market leadership, a great customer experience and profitable growth creating opportunities to provide more value-added services. This will be underpinned by investment in those areas that support scalable and efficient delivery of a high quality, excellent clinical service to patients.
Finally, on behalf of the Board, I would like to thank everyone across the Group for their commitment and passion during a year that, whilst being undoubtedly challenging, marks a further successful step in the overall transformation of the Group.
Annual Report 2012-2013 Final LR